Mycodern (WAR:MCD) Other Current Receivables: zł0.03 Mil (As of Mar. 2026)

Mycodern WAR:MCD 29 Other Current Receivables is zł0.03 Mil as of Mar. 2026. GuruFocus rates WAR:MCD with a GF Score™ of 29/100 and a GF Value™ of zł0.35 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Mycodern's Other Current Receivables for the quarter that ended in Mar. 2026 was zł0.03 Mil.

Mycodern's quarterly Other Current Receivables declined from Sep. 2025 (zł0.23 Mil) to Dec. 2025 (zł0.03 Mil) but then stayed the same from Dec. 2025 (zł0.03 Mil) to Mar. 2026 (zł0.03 Mil).

Mycodern's annual Other Current Receivables declined from Dec. 2023 (zł0.01 Mil) to Dec. 2024 (zł0.01 Mil) but then increased from Dec. 2024 (zł0.01 Mil) to Dec. 2025 (zł0.03 Mil).

Mycodern Other Current Receivables Related Terms

Mycodern Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Mycodern's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mycodern Other Current Receivables Chart

Mycodern Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Other Current Receivables

Get a 7-Day Free Trial

0.00

0.01

0.03

Mycodern Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Other Current Receivables	Get a 7-Day Free Trial															0.23	0.23	0.23	0.03	0.03

29GF Score

Mycodern SA WAR:MCD

Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Mycodern Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Frequently Asked Questions Learn more about Other Current Receivables →

What does a Other Current Receivables of zł0.03 Mil mean?

Mycodern (WAR:MCD) has a Other Current Receivables of zł0.03 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Mycodern and its competitors.

Is Mycodern's Other Current Receivables too high?

Mycodern's current Other Current Receivables is zł0.03 Mil. Overall, Mycodern has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Mycodern's Other Current Receivables compare to KHC and GIS?

Mycodern's Other Current Receivables of zł0.03 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Other Current Receivables for a Consumer Packaged Goods company?

A good Other Current Receivables depends on the Consumer Packaged Goods industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Other Current Receivables mean?

A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Mycodern and its competitors. Mycodern's current Other Current Receivables is zł0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Mycodern stock overvalued right now?

Based on GuruFocus' analysis, Mycodern (WAR:MCD) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.35, compared to a current price of zł0.78 — trading 122.9% above its estimated fair value. The current Other Current Receivables is zł0.03 Mil. Mycodern's overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Other Current Receivables calculated?

Other Current Receivables is calculated from a company's financial statements. For Mycodern (WAR:MCD), the current Other Current Receivables is zł0.03 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mycodern (WAR:MCD) Overvalued in 2026?

Based on GuruFocus' analysis, Mycodern stock appears to be overvalued. The current stock price of zł0.78 is trading 122.9% above its estimated GF Value™ of zł0.35. GuruFocus considers Mycodern to be Significantly Overvalued.

Key valuation signals for WAR:MCD:

Other Current Receivables: zł0.03 Mil
GF Value™: zł0.35 vs. price of zł0.78 (122.9% above fair value)
GF Score™: 29/100 with 1 warning sign

No single metric tells the full story. See the WAR:MCD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.